title: Letter by Argulian and Messerli regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
authors.affiliation: Mount Sinai St. Luke's Hospital, Division of Cardiology, Mount Sinai Health System, New York, NY.
authors.forename: Edgar
authors.initials: E
authors.lastname: Argulian
authors.affiliation: Mount Sinai Health Medical Center, Icahn School of Medicine, New York, NY.
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*; D062645:Percutaneous Coronary Intervention; D011292:Premedication
chemical_list: D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D008790:Metoprolol